欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0272/001
药品名称Meropenem Kabi
活性成分
    • Meropenem trihydrate 570.0 mg
剂型Powder for solution for infusion/injection
上市许可持有人Fresenius Kabi Pharma Portugal, Lda
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Germany (DE)
      Meropenem Kabi 500 mg Pulver zur Herstellung einer Injektionslösung oder Infusionslösung
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Meropenem Kabi 500 mg Pulver zur Herstellung einer Injektionslösung oder Infusionslösung
    • Spain (ES)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
    • Lithuania (LT)
      Meropenem Kabi 500 mg milteliai injekciniam ar infuziniam tirpalui
    • Hungary (HU)
      MEROPENEM KABI 500 mg por oldatos injekcióhoz vagy infúzióhoz
    • Cyprus (CY)
      MEROPENEM KABI 500mg PWD FOR SOLUTION FOR INJECTION OR INFUSION
    • Czechia (CZ)
      Meropenem Kabi 500 mg
    • Romania (RO)
      Meropenem Kabi 500mg, pulbere pentru soluţie injectabilă sau perfuzabilă
    • Slovakia (SK)
      Meropenem Kabi 500 mg
    • Slovenia (SI)
许可日期2010/06/09
最近更新日期2025/09/19
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase